Farletuzumab (MORAb-003) is a humanized monoclonal antibody with a high affinity for folate receptor-alpha (FRalpha), acting as a potent inhibitor of FRalpha and impeding the growth of cells that overexpress this receptor, making it useful for cancer research.
Purity:
>95%
CAS Number:
[896723-44-7]
Target:
Antibiotic|||Antifolate
* VAT and and shipping costs not included. Errors and price changes excepted